Sandeep Jadhav: How Nutritional Deficiencies Can Act as Hidden Pro-Thrombotic Risk Factors
Sandeep Jadhav, Graduated Doctor at Bapuji Pharmacy College, shared a post on LinkedIn about an article he and his colleagues co-authored, published in World Journal of Pharmaceutical Research, adding:
“Glad to share this insightful published case report on Hydropneumothorax associated with bilateral pulmonary thromboembolism, complicated by severe Vitamin B12 deficiency and hyperhomocysteinemia.
This case highlights how nutritional deficiencies can act as hidden pro-thrombotic risk factors, even in younger patients without traditional risk factors. Early diagnosis through CECT, timely ICD insertion, anticoagulation, and B12 supplementation played a crucial role in management.
Grateful to my co-authors and mentors for their guidance, collaboration, and support throughout this case work – truly a valuable learning experience.”
Title: A Case Report on Hydropneumothorax
Authors: Aswan Kumar Reddy K. V., Harshith M. Pisale, S. Jabeen Taj, Sandeep Jadhav, Amruthavarshini R.
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 26, 2026, 10:59Wolfgang Miesbach: How Clonal Hematopoiesis May Explain Age-Related Mitochondrial Mutations
-
Jun 26, 2026, 10:52Chinua Onyebuchi: The Future of Stroke Care in Africa Lies in Strong Health Systems
-
Jun 26, 2026, 10:35Habtamu Milkias Wolde: New Insights into Stroke and Traumatic Brain Injury from Global Burden of Disease Data
-
Jun 26, 2026, 10:19Rytis Masiliūnas: Atrial Fibrillation and Stroke Care Disparities Across the Baltic Region
-
Jun 26, 2026, 10:11Kayla Kilani: First-Ever CT Perfusion Scan Performed Inside a Mobile Stroke Unit
-
Jun 26, 2026, 07:38Baraa Nassar: High Clinical Suspicion Is Essential for Early Diagnosis of CVST
-
Jun 26, 2026, 07:10Saleh Shamse Basha: Why APTT Alone Can Be Misleading During UFH Monitoring
-
Jun 26, 2026, 06:01Nicolas Hubacz: A Sharper Look at the Brain’s Vascular Landscape
-
Jun 26, 2026, 05:57Ayse Bahar Keleşoğlu Dinçer: New Insights into Antiphospholipid Syndrome Classification and Recurrent Thrombosis Risk